R33_MDD
Brief description of study
The purpose of this study is to investigate whether brain responses within the subgenual anterior cingulate cortex (sgACC) are associated with clinical improvement following transcranial magnetic stimulation (TMS) treatment in individuals with depression. Participants will be randomized to receive either active or sham intermittent theta-burst stimulation (iTBS) delivered to an individualized, fMRI-guided cortical target over a 6-week treatment course. The study will examine whether sgACC responses measured using interleaved TMS and functional magnetic resonance imaging (TMS/fMRI) before treatment predict antidepressant response and whether changes in sgACC responses throughout treatment are associated with changes in depressive symptoms. Study participation will include clinical interviews, questionnaires, MRI scans, interleaved TMS/fMRI sessions conducted before, during, and after treatment, and weekday TMS sessions for approximately 6 weeks.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Medical Research
-
Age: 99 years or below
-
Gender: All
TBD
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or